Skip to main content
CHEIL BIO CO., LTD. logo

CHEIL BIO CO., LTD. — Investor Relations & Filings

Ticker · 052670 ISIN · KR7052670007 KO Manufacturing
Open in API
Filings indexed 291 across all filing types
Latest filing 2026-01-27 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 052670

About CHEIL BIO CO., LTD.

http://www.cheilbio.com/en/index.php

CHEIL BIO CO., LTD. is a company that develops, manufactures, and markets a wide range of advanced veterinary products. The company focuses on improving the health and productivity of livestock through solutions based on extensive research and biotechnology. Its core offerings include animal medicines, such as antibiotics and antimicrobials, and functional feed additives. These products cater to a diverse market, including the swine, poultry, cattle, and aquaculture sectors, as well as companion animals. The company leverages its dedicated research and development capabilities to create high-quality, market-competitive products and aims to achieve global technological competitiveness in the animal health industry.

Recent filings

Filing Released Lang Actions
[기재정정]액면주식ㆍ무액면주식전환결정
Share Issue/Capital Change Classification · 95% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding a correction (amendment) to a previous announcement about the conversion of par-value shares to no-par-value shares. Since this involves a change in the capital structure and share characteristics, it falls under the category of share/capital changes. While it is a correction, it is a substantive update to a corporate action rather than a simple report publication announcement.
2026-01-27 Korean
[기재정정]액면주식ㆍ무액면주식전환결정
Share Issue/Capital Change Classification · 95% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding a 'Correction Report' (정정신고) for a decision to convert par-value shares to no-par-value shares. This involves a change in the company's capital structure and share characteristics. Since it relates to a change in share type and capital structure, it falls under the 'Share Issue/Capital Change' category (SHA).
2026-01-26 Korean
[기재정정]액면주식ㆍ무액면주식전환결정
Share Issue/Capital Change Classification · 98% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding a correction ('정정신고') to a previous announcement about the conversion of par-value shares to no-par-value shares. It details changes to the listing schedule for new shares following a court decision. Since this is a specific corporate action regarding capital structure and share status, it falls under 'Share Issue/Capital Change' (SHA).
2026-01-26 Korean
소송등의판결ㆍ결정 (효력정지가처분)
Legal Proceedings Report Classification · 100% confidence The document is a formal announcement regarding a court decision (injunction/lawsuit outcome) involving '제일바이오' (Jeil Bio). It details the case name, court, decision date, and the ruling content. This falls under legal proceedings and regulatory disclosures regarding litigation, which matches the 'Legal Proceedings Report' category.
2026-01-23 Korean
기타시장안내 (상장폐지결정 효력정지 가처분신청 기각 및 상장폐지 절차 관련 안내)
Delisting Announcement Classification · 100% confidence The document is an official announcement from the Korea Exchange (KRX) regarding the dismissal of a court injunction against a delisting decision for Jeil Bio. It details the legal status of the delisting process, the court's decision, and the subsequent timeline for delisting. Since this document specifically concerns the removal of the company's stock from the exchange, it falls under the Delisting Announcement category.
2026-01-09 Korean
횡령ㆍ배임혐의진행사항
Legal Proceedings Report Classification · 100% confidence The document details ongoing legal proceedings related to embezzlement and breach of trust allegations against a former executive of the company. It includes specific information about the amount involved, legal actions taken, and references to previous related disclosures. There are no financial statements or report data, but rather updates on a legal matter. This fits the definition of a Legal Proceedings Report (LTR). The document length is short and focused solely on legal updates, not a full financial or management report.
2025-11-04 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.